Showing 401-420 of 746 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Intravenous dexamethasone for extubation of newborn infants
Cochrane Systematic Reviews, 23-Oct-2001
Endotracheal tubes are foreign bodies that may injure the upper airway causing laryngeal edema. This in turn may result in failure of extubation in preterm infants. Corticosteroids have been used prophylactically to reduce upper airway obstruction and fac
- Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 20-Dec-2013
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes progressive or relapsing weakness and numbness of the limbs, developing over at least two months. Uncontrolled studies suggest that intravenous immunoglobulin (IVIg) helps. This revie
- Intravenous immunoglobulin for Guillain‐Barré syndrome
Cochrane Systematic Reviews, 19-Sep-2014
Guillain-Barré syndrome (GBS) is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin (IVIg) is beneficial in other autoimmune diseases. This is an update of a review first published in 2001 and previously updated in 200
- Intravenous immunoglobulin for myasthenia gravis
Cochrane Systematic Reviews, 12-Dec-2012
Myasthenia gravis is an autoimmune disease in which autoantibodies interfere with neuromuscular transmission. As with other autoimmune diseases, people with myasthenia gravis would be expected to benefit from intravenous immunoglobulin (IVIg). This is an
- Intravenous immunoglobulin for presumed viral myocarditis in children and adults
Cochrane Systematic Reviews, 19-Aug-2020
This is an update of a previous review. Case reports and case series have described dramatic responses to intravenous immunoglobulin (IVIG) in people with presumed viral myocarditis, and its administration has become commonplace.
- Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants
Cochrane Systematic Reviews, 29-Jan-2020
Nosocomial infections continue to be a significant cause of morbidity and mortality among preterm and/or low birth weight (LBW) infants. Preterm infants are deficient in immunoglobulin G (IgG); therefore, administration of intravenous immunoglobulin (IVIG
- Intravenous immunoglobulin for suspected or proven infection in neonates
Cochrane Systematic Reviews, 29-Jan-2020
Neonates are at higher risk of infection due to immuno-incompetence. Maternal transport of immunoglobulins to the fetus mainly occurs after 32 weeks' gestation, and endogenous synthesis begins several months after birth. Administration of intravenous immu
- Intravenous immunoglobulin for the treatment of Kawasaki disease in children
Cochrane Systematic Reviews, 20-Oct-2003
Kawasaki disease is the most common cause of acquired heart disease in children in developed countries. The coronary arteries supplying the heart can be damaged in Kawasaki disease. The principal advantage of timely diagnosis is the potential to prevent t
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Cochrane Systematic Reviews, 16-Sep-2013
Mortality from sepsis and septic shock remains high. Results of trials on intravenous immunoglobulins (IVIG) as adjunctive therapy for sepsis have been conflicting. This is an update of a Cochrane review that was originally published in 1999 and updated i
- Intravenous immunoglobulins for multiple sclerosis
Cochrane Systematic Reviews, 21-Jul-2003
Animal experiments suggest that intravenous immunoglobulins can reverse some of the disease process of central nervous system demyelination. Subsequently, clinical trials of intravenous immunoglobulins have been conducted in people with multiple sclerosis
- Intravenous lidocaine for the treatment of background or procedural burn pain
Cochrane Systematic Reviews, 16-Oct-2014
This is an update of the review on "Lidocaine for pain relief in burn injured patients" first published in Issue 3, 2007, and first updated in 2012. Pain is a major issue for people with many different types of wounds, in particular those people with burn
- Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease
Cochrane Systematic Reviews, 7-Sep-2011
Lung disease in preterm infants is often complicated with lung edema.
- Intraventricular antibiotics for bacterial meningitis in neonates
Cochrane Systematic Reviews, 11-Jul-2012
Neonatal meningitis may be caused by bacteria, especially gram-negative bacteria, which are difficult to eradicate from the cerebrospinal fluid (CSF) using safe doses of antibiotics. In theory, intraventricular administration of antibiotics would produce
- Intraventricular streptokinase after intraventricular hemorrhage in newborn infants
Cochrane Systematic Reviews, 17-Oct-2007
Hydrocephalus following intraventricular hemorrhage (IVH) is still one of the most serious complications of premature birth. Ventriculoperitoneal shunt surgery cannot be carried out early and permanent dependence on a shunt is associated with several seri
- Intravesical treatments for painful bladder syndrome/ interstitial cystitis
Cochrane Systematic Reviews, 17-Oct-2007
Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC) occurs predominantly in women. It is a poorly-understood condition with symptoms of bladder pain, urinary frequency, urgency and nocturia. Treatments for PBS/IC include dietary/lifestyle intervention
- Intravitreal steroids for macular edema in diabetes
Cochrane Systematic Reviews, 17-Nov-2020
Diabetic macular edema (DME) is secondary to leakage from diseased retinal capillaries with thickening of central retina, and is an important cause of poor central visual acuity in people with diabetic retinopathy. Intravitreal steroids have been used to
- Ipratropium bromide versus long‐acting beta‐2 agonists for stable chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 19-Jul-2006
Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with long acting beta-2 agonists (LABAs) and anticholinergic bronchodilator medi
- Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 19-Apr-2006
Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with short-acting beta-2 agonists (SABA) and anticholinergic bronchodilator medi
- Ketotifen alone or as additional medication for long‐term control of asthma and wheeze in children
Cochrane Systematic Reviews, 26-Jan-2004
Ketotifen is an antihistamine which may be used to treat asthma. Since administering inhaled therapy to younger children can be difficult, an oral agent such as ketotifen offers potential advantages.
- Kinesthetic stimulation versus methylxanthine for apnea in preterm infants
Cochrane Systematic Reviews, 27-Apr-1998
Apnea of prematurity may lead to hypoxemia and bradycardia requiring resuscitative measures being instituted. Many treatments have been used in infants with apnea of prematurity including methylxanthines. Physical stimulation is often used to restart brea
